Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

457P - The prevalence of vitamin D deficiency in Thai cancer patients, its dynamics and association with cancer survival

Date

23 Nov 2019

Session

Poster display session

Topics

Supportive Care and Symptom Management

Tumour Site

Presenters

Chavapon Ngokngarm

Citation

Annals of Oncology (2019) 30 (suppl_9): ix140-ix150. 10.1093/annonc/mdz434

Authors

C. Ngokngarm1, C. Bandidwattanawong2

Author affiliations

  • 1 Medicine, Vajira Hospital Centre, 10300 - Bangkok/TH
  • 2 Medicine, Bangkok Metropolitan Administration Medical School and Vajira Hospital, 10300 - Pathumwan/TH

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 457P

Background

Vitamin D deficiency is associated with various kinds of cancer. Moreover, vitamin D level possibly has an inverse relationship with cancer mortality. The data on vitamin D status among Thai cancer patients and its association with cancer survival are scarce. Objectives: The primary outcome was to determine the prevalence of vitamin D deficiency among unselected Thai cancer patients. The secondary outcomes were to explore the effect of cancer treatment upon vitamin D status, the independent predictive factor(s) of vitamin D deficiency among cancer patients and its potential independent factor of cancer survival.

Methods

There were 106 consecutive cancer patients participated in this prospective descriptive study conducted at Division of Medical Oncology. Vitamin D (25(OH) D) levels were collected before and after cancer treatment. Demographic data, vitamin D status, and treatment outcomes were collected and analysed.

Results

There were 106 consecutive cancer patients participated in this study. Determination of vitamin D status after cancer treatment were obtained in 76 patients. The investigators found that almost all of the cancer patients had vitamin D deficiency (102 of 106, 96.2%). Determination of vitamin D status after cancer treatment were obtained in 76 patients. The investigators did not demonstrate the significant change of vitamin D level (mean change = -1.46 (95% C.I., -3.33-0.41), p = 0.124) when the blood samples were collected before and after cancer treatment. Therefore, cancer treatment was unlikely to affect the vitamin D status. There was a trend towards inverse relationship between the BMI and vitamin D level. At the median follow-up time of 254.5 days (IQR 220-297), the investigators revealed that low BSA (BSA < 1.5 m2), PS 2 at presentation was the independent predictive factors of survival, according to the multi-variate analysis.

Conclusions

Nearly all Thai cancer patients have vitamin D deficiency. Cancer treatment does not affect the vitamin D status. Low serum vitamin D level does not affect survival outcome.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Chavapon Ngokngarm/Vajira hospital, Thailand.

Funding

Medical Research Fund of Faculty Medicine Vajira Hospital, Navamindradhiraj University.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.